{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Somatostatin antagonists and agonists that act at the SST subtype 2 receptor", "item": "https://www.patentleaderboard.com/patent/6495589"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Somatostatin antagonists and agonists that act at the SST subtype 2 receptor

Somatostatin antagonists and agonists that act at the SST subtype 2 receptor

US Patent 6495589 · Granted Dec 17, 2002

Estimated economic value: $317,881,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Charged ion channel blockers and methods for use2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Crystalline forms of 4-ethoxy-n-(2-methoxyethyl)-n-methyl-3-(5-methyl-4-oxo-7-pr2025
Population control using engineered translocations2025
Charged ion channel blockers and methods for use2025
Charged ion channel blockers and methods for use2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing toll-like recep2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2023